Navigation Links
Insmed Announces Fourth Quarter and Full-Year 2010 Financial Results
Date:3/10/2011

RICHMOND, Va., March 10, 2011 /PRNewswire/ -- Insmed Inc. (Nasdaq CM: INSMD), a biopharmaceutical company, today reported results for the fourth quarter and full-year ended December 31, 2010.

Key Recent Highlights:

  • Filed Investigational New Drug (IND) Application in February 2011 with the FDA to begin a phase 3 clinical trial for ARIKACE™ (liposomal amikacin for inhalation) in non-TB Mycobacteria (NTM) lung infections.
  • Successfully concluded 72 week phase 2b open-label study for ARIKACE for pseudomonas lung infections in cystic fibrosis (CF) patients.
  • Received positive opinion from European Medicines Agency (EMA) on Company's Pediatric Investigation Plan for ARIKACE in the CF indication.
  • Gained shareholder approval for conversion of preferred stock into common stock and 1:10 reverse stock split.

  • "Following the closure of our transformative business combination in December 2010, we have been aggressively moving forward with the development plan for ARIKACE, our phase 3 compound for pseudomonas lung infections for CF patients, and NTM lung infections," said Timothy Whitten, Insmed's President & CEO.  "We are well underway with the initial preparations and necessary work around these trials and continue to expect to begin accruing patients to the phase 3 trials in both indications in the second half of 2011, with results expected in the first half of 2013."

    Financial ResultsOn March 1, 2011, at a special meeting, our shareholders approved a one for 10 reverse stock split of our common stock, which became effective at 5:00 pm EST on March 2, 2011.  This reverse stock split is reflected in the shares outstanding and earnings per share calculations below.  

    Revenues for the fourth quarter ended December 31, 2010 were $1.3 million, as compared to $2.5 million for the corresponding period in 2009.  The $1.2 million decrease resulted from $0.6 million in lower cost r
    '/>"/>

    SOURCE Insmed Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related biology technology :

    1. Insmed to Host Second Quarter 2009 Conference Call
    2. Insmed Announces Addition to the Russell 3000(R) Index
    3. Insmed Announces Results of IPLEX(TM) Phase II Trial in Myotonic Muscular Dystrophy
    4. Insmed CEO Resigns Due to Health Concerns
    5. Insmed Announces First Quarter 2009 Financial Results
    6. Insmed Regains NASDAQ Compliance
    7. Insmed to Host First Quarter 2009 Conference Call
    8. Insmed Announces Agreement With IDIS to Manage Expanded Access Programs for IPLEX(TM)
    9. Insmed Announces That NASDAQ Further Extends Temporary Suspension of Minimum Bid Closing Price Rule
    10. Insmed Announces Fourth Quarter and Full-Year 2008 Financial Results
    11. Insmed to Host Fourth Quarter and Full-Year 2008 Conference Call
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/15/2014)...   Niagara Thermal Products is proud to announce ... LLC ("B3") as the critical thermal component supplier in ... Army Corps of Engineers.  B3 has developed the only ... and destroys VOCs and other chemical pollutants, allergens and ...
    (Date:1/15/2014)... (PRWEB) January 15, 2014 Cynvenio, a ... management through the genomic analysis of tumor cells in ... Finder™, a web-based cancer decision support application powered by ... with Cynvenio’s ClearID™ genomic test, Therapy Finder will provide ...
    (Date:1/15/2014)... , Jan. 15, 2014 ­ RedBrick Health ... behavior change technology, today announces that EmblemHealth , ... and wellness company, is now providing the RedBrick Compass ... coaching program, to all of its members. EmblemHealth is ...
    (Date:1/15/2014)... A study has been launched to test whether technology ... help to tackle the problem of obesity.  This unique healthcare ... based in Stowmarket) and academics at University Campus Suffolk is ... which is inspired by equipment used to collect data about ...
    Breaking Biology Technology:Niagara Thermal Products LLC Selected as Critical Supplier for Buffalo BioBlower Air Purification Systems 2Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 2Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 3EmblemHealth Selects RedBrick Health to Power its Next-Generation Health Engagement and Behavior Change System 2EmblemHealth Selects RedBrick Health to Power its Next-Generation Health Engagement and Behavior Change System 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 2Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 4
    ... VIGILAIR Systems, an industry leader in Ultraviolet ... published, and first of its kind hospital study that ... (HAI) with the application of VIGILAIR® air cleaning technology ... The published article , Effect of enhanced ultraviolet germicidal ...
    ... BioNeutral Group, Inc. (OTCBB: BONU), a specialty life science ... J.D., as a new member to its Board of Directors. ... Wharton School of Business, University of Pennsylvania and received his ... been an attorney in the state of New Jersey since ...
    ... Sangamo BioSciences, Inc. (Nasdaq: SGMO ) announced ... its common stock pursuant to an effective shelf registration statement ... sole book-running manager in this offering and Sangamo will grant ... to 1,005,000 additional shares. The securities described ...
    Cached Biology Technology:Newly Published Study Shows Dramatic Reduction in Hospital Acquired Infections 2BioNeutral Appoints Michael D. Francis, J.D. as Director to the Board 2BioNeutral Appoints Michael D. Francis, J.D. as Director to the Board 3Sangamo Announces Public Offering of Common Stock 2Sangamo Announces Public Offering of Common Stock 3
    (Date:4/16/2014)... TALLAHASSEE, Fla. Florida State University researchers have identified ... deterioration of bone density and muscle mass with obesity. ... heavier you were the better your bones would be ... Ilich-Ernst, the Hazel Stiebeling Professor of Nutrition at Florida ...
    (Date:4/16/2014)... Sometimes known as Kennedy,s disease, spinal and bulbar muscular atrophy ... progressive muscle weakness and atrophy. Researchers have long considered it ... the cells in the spinal cord and brainstem that control ... the April 16, 2014 online issue of Neuron , ...
    (Date:4/16/2014)... , , Everything we do all of our movements, thoughts ... one another, and recent studies have suggested that some of ... known as astrocytes may be listening in on, or even ... study suggests that astrocytes might only be tuning in part ...
    Breaking Biology News(10 mins):Researchers: Obesity can amplify bone and muscle loss 2Mutant protein in muscle linked to neuromuscular disorder 2Eavesdropping on brain cell chatter 2Eavesdropping on brain cell chatter 3
    ... BIO-key International, Inc.,(OTC Bulletin Board: BKYI), a leader ... that the U.S. Patent and Trademark,Office has approved the ... within a Biometric Security System" method. , ... protected by this patent (patent number,7,454,624) provide another layer ...
    ... Ore. December 3, 2008. The first 5-year forest inventory ... available to the public: California,s Forest Resources, 2001-2005: Five-Year ... findings from the report:, , Forests cover about ... acres is publicly managed. , Houses built in the ...
    ... Institution of Oceanography at UC San Diego returning ... details of vibrant sea life and ecosystems in ... species and marine animals previously never seen alive. ... depths, have revealed disturbing declines in sea-life populations ...
    Cached Biology News:BIO-key(R) Granted Patent to Secure Biometric Enrollments From Unauthorized Use 2Forest inventories in California include more than trees 2Forest inventories in California include more than trees 3Expeditions reveal gulf of California's deep sea secrets, as well as human imprints 2Expeditions reveal gulf of California's deep sea secrets, as well as human imprints 3Expeditions reveal gulf of California's deep sea secrets, as well as human imprints 4
    Mouse monoclonal antibody raised against a partial recombinant DHX8. NCBI Entrez Gene ID = DHX8...
    ... Mouse polyclonal antibody raised ... Immunogen: ... 241 a.a) partial recombinant protein ... Accession Number: NM_004693 ...
    ... DNA Visualizer DX's sensitivity of DNA detection has ... band in an agarose gel can be detected ... kit can be purified by organic solvent extraction ... commercially kits worked well.) DNA excised from ...
    Mouse monoclonal antibody raised against a full length recombinant CSNK2A2. NCBI Entrez Gene ID = CSNK2A2...
    Biology Products: